tiprankstipranks
Trending News
More News >

China NT Pharma Clarifies Financial Figures in Major Acquisition

Story Highlights
  • China NT Pharma operates in the pharmaceutical industry, focusing on healthcare solutions in China.
  • The company clarified financial figures for its acquisition, ensuring accurate reporting for stakeholders.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
China NT Pharma Clarifies Financial Figures in Major Acquisition

Don’t Miss TipRanks’ Half-Year Sale

China NT Pharma Group Co., Ltd. ( (HK:1011) ) has issued an update.

China NT Pharma Group Co., Ltd. has issued a clarification regarding its acquisition of 100% of the issued shares in target companies, involving the issuance of consideration shares under a specific mandate. The company corrected financial figures for its PRC Operating Company for the years ending December 2023 and 2024, stating that the figures should be in RMB rather than thousands of RMB. This clarification ensures accurate financial reporting, which is crucial for stakeholders assessing the company’s financial health and strategic acquisitions.

More about China NT Pharma Group Co., Ltd.

China NT Pharma Group Co., Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is primarily engaged in providing healthcare solutions in the Chinese market.

YTD Price Performance: 48.15%

Average Trading Volume: 387,364

Technical Sentiment Signal: Hold

Current Market Cap: HK$269.7M

For an in-depth examination of 1011 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1